Nilay Shah
Nationwide Children's Hospital · Mayo Clinic · The Emmes Company, LLC
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Nilay Shah as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 10:41 UTC. Open this list on ClinicalTrials.gov
- Ph2NCT05135975 · A Study of Cabozantinib as a Maintenance Agent to Prevent Progression or Recurrence in High-Risk Pediatric Solid TumorsNationwide Children's Hospital · recruiting · Neuroblastoma, Sarcoma · principal investigator
- N/ANCT03436082 · Post-Market Surveillance With a Novel mHealth PlatformYale University · completed · Gastrectomy, Atrial Fibrillation · principal investigator
- N/ANCT01771536 · The PCI Choice Trial: a Pilot Randomized Trial of a Decision Aid for Patients With Stable Coronary Artery DiseaseMayo Clinic · completed · Stable Angina · principal investigator
- N/ANCT01282346 · SOLX Gold Shunt for Refractory GlaucomaSOLX, Inc. · completed · Glaucoma, Glaucoma, Open Angle · study director
Grants
NIH projects from RePORTER, fetched 2026-11-12 10:41 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. 5 other NIH projects list an investigator with the same name at a different institution and are left out. Coverage is US federal funding only; UK and EU funders are not searched yet.
- The ICAN Discussion Aid to Optimize Treatment for People Living with Multiple Chronic ConditionsR03HS025517 · AHRQ · MAYO CLINIC ROCHESTER · fiscal years 2017 to 2018 · $30,143 awarded in 2018Same name and institution; not confirmed by an ID
- Translating Information on Comparative Effectiveness into PracticeR18HS018339 · AHRQ · MAYO CLINIC ROCHESTER · fiscal years 2009 to 2013 · $249,039 awarded in 2013Same name and institution; not confirmed by an ID
- Optimizing the Treatment of Diabetes PatientsR21HS017628 · AHRQ · MAYO CLINIC ROCHESTER · fiscal years 2008 to 2009 · $139,872 awarded in 2009Same name and institution; not confirmed by an ID
Most cited trial papers
PubMed returned no clinical-trial papers for this author name in ewing sarcoma.